How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Bringing quantitative neuroimaging to neurodegenerative disease care on the Rapid Enterprise Platform

calendar_today November 4, 2026 person RapidAI Editorial Team domain rapidai

An estimated 7.4 million Americans age 65 and older are living with Alzheimer’s disease in 2026, a number that could reach 13.8 million by 2060.¹ Nearly 1 million more Americans are living with multiple sclerosis (MS).² For neuroscience service lines, these figures mean sustained demand across diagnosis, treatment and long-term monitoring, with imaging at the center of each.

open_in_new Read original post